NICOLE LYONS: Open Payments
NPI 1093121600 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,286 in 71 payments from 10 companies in 2025. Trend: 2023 $1,216 · 2024 $1,590 · 2025 $3,286
Food & beverage: $1,792Travel & lodging: $1,390Education: $104
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 3 | $1,545 |
| Teva Pharmaceuticals USA, Inc. | 15 | $378 |
| Neurocrine BioSciences, Inc. | 11 | $297 |
| Alkermes, Inc. | 9 | $297 |
| ABBVIE INC. | 9 | $236 |
| E.R. Squibb & Sons, L.L.C. | 10 | $230 |
| Janssen Pharmaceuticals, Inc | 7 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, INGREZZA, COBENFY, VRAYLAR, ARISTADA, UZEDY, LYBALVI, SPRAVATO.
Industry payments across AZ — which companies pay providers there.
